Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen Hu

Showing results (961-970 of 1,174) with videos related to

Pageof 118
Sort By:
Environment International|March 5, 2019
Prenatal exposure to benzophenones, parabens and triclosan and neurocognitive development at 2 yearsYangqian Jiang, Hongzhi Zhao, Wei Xia, et al.
European Journal of Medicinal Chemistry|September 19, 2020
Discovery of (E)-N-(4-methyl-5-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thiazol-2-yl)-2-(4-methylpiperazin-1-yl)acetamide (IHMT-TRK-284) as a novel orally available type II TRK kinase inhibitor capable of overcoming multiple resistant mutantsBeilei Wang, Wentao Zhang, Xuesong Liu, et al.
Nature Communications|January 5, 2021
The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylationGuangjian Fan, Lianhui Sun, Ling Meng, et al.
Journal of Medicinal Chemistry|October 19, 2021
Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell LymphomasBin Zhou, Xiaofei Liang, Husheng Mei, et al.
Thoracic Cancer|October 4, 2022
Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancerJie Zheng, Yubo Wang, Chen Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 TrialTimothy Lin, Suqi Ke, Chen Hu, et al.
Journal for Immunotherapy of Cancer|June 22, 2024
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effectConghua Lu, Ziyuan Gao, Di Wu, et al.
Cell Reports|February 5, 2025
Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapyLianhui Sun, Guangjian Fan, Zhuqing Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 29, 2019
Coactivation of Endogenous Wnt10b and Foxc2 by CRISPR Activation Enhances BMSC Osteogenesis and Promotes Calvarial Bone RegenerationMu-Nung Hsu, Kai-Lun Huang, Fu-Jen Yu, et al.
Acta Pharmacologica Sinica|May 30, 2017
A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancerXin-Shuai Wang, De-Jiu Kong, Tzu-Yin Lin, et al.
Pageof 118

Showing results (961-970 of 1,174) with videos related to

Sort By:
Pageof 118
Environment International|March 5, 2019
Prenatal exposure to benzophenones, parabens and triclosan and neurocognitive development at 2 yearsYangqian Jiang, Hongzhi Zhao, Wei Xia, et al.
European Journal of Medicinal Chemistry|September 19, 2020
Discovery of (E)-N-(4-methyl-5-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thiazol-2-yl)-2-(4-methylpiperazin-1-yl)acetamide (IHMT-TRK-284) as a novel orally available type II TRK kinase inhibitor capable of overcoming multiple resistant mutantsBeilei Wang, Wentao Zhang, Xuesong Liu, et al.
Nature Communications|January 5, 2021
The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylationGuangjian Fan, Lianhui Sun, Ling Meng, et al.
Journal of Medicinal Chemistry|October 19, 2021
Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell LymphomasBin Zhou, Xiaofei Liang, Husheng Mei, et al.
Thoracic Cancer|October 4, 2022
Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancerJie Zheng, Yubo Wang, Chen Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 TrialTimothy Lin, Suqi Ke, Chen Hu, et al.
Journal for Immunotherapy of Cancer|June 22, 2024
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effectConghua Lu, Ziyuan Gao, Di Wu, et al.
Cell Reports|February 5, 2025
Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapyLianhui Sun, Guangjian Fan, Zhuqing Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 29, 2019
Coactivation of Endogenous Wnt10b and Foxc2 by CRISPR Activation Enhances BMSC Osteogenesis and Promotes Calvarial Bone RegenerationMu-Nung Hsu, Kai-Lun Huang, Fu-Jen Yu, et al.
Acta Pharmacologica Sinica|May 30, 2017
A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancerXin-Shuai Wang, De-Jiu Kong, Tzu-Yin Lin, et al.
Pageof 118